Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Viking Therapeutics, Inc. | 191,371 | reported | 05 Jan 2026 | tx 104+1,690,502−1,210,563 |
| SANGAMO THERAPEUTICS, INC | 0 | reported | 14 Feb 2008 | tx 67+252,875−143,219 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 02 Jan 2026 | GRANT_AWARD | Viking Therapeutics, Inc. | 41,000 | 0.00 USD | |
| 02 Jan 2026 | GRANT_AWARD | Viking Therapeutics, Inc. | 32,049 | 0.00 USD | |
| 05 Jan 2026 | SALE | Viking Therapeutics, Inc. | 31,961 | 32.30 USD | |
| 05 Jan 2026 | SALE | Viking Therapeutics, Inc. | 13,900 | 33.38 USD | |
| 05 Jan 2026 | SALE | Viking Therapeutics, Inc. | 10,300 | 34.24 USD | |
| 05 Jan 2026 | SALE | Viking Therapeutics, Inc. | 1,500 | 32.09 USD | |
| 02 Jan 2026 | GRANT_AWARD | Viking Therapeutics, Inc. | 91,000 | 0.00 USD | deriv |
| 28 Oct 2025 | SALE | Viking Therapeutics, Inc. | 6,185 | 35.00 USD | |
| 27 Oct 2025 | GRANT_AWARD | Viking Therapeutics, Inc. | 11,117 | 0.00 USD | |
| 03 Jul 2025 | SALE | Viking Therapeutics, Inc. | 4,266 | 27.76 USD | |
| 02 Jul 2025 | GRANT_AWARD | Viking Therapeutics, Inc. | 7,667 | 0.00 USD | |
| 03 Jan 2025 | GRANT_AWARD | Viking Therapeutics, Inc. | 44,533 | 0.00 USD | |
| 03 Jan 2025 | GRANT_AWARD | Viking Therapeutics, Inc. | 21,667 | 0.00 USD | |
| 06 Jan 2025 | SALE | Viking Therapeutics, Inc. | 4,700 | 43.32 USD | |
| 06 Jan 2025 | SALE | Viking Therapeutics, Inc. | 45,609 | 42.69 USD | |
| 03 Jan 2025 | GRANT_AWARD | Viking Therapeutics, Inc. | 37,200 | 0.00 USD | deriv |
| 28 Oct 2024 | EXERCISE | Viking Therapeutics, Inc. | 51,000 | 8.52 USD | |
| 28 Oct 2024 | SALE | Viking Therapeutics, Inc. | 49,672 | 74.56 USD | |
| 28 Oct 2024 | SALE | Viking Therapeutics, Inc. | 18,620 | 75.79 USD | |
| 28 Oct 2024 | SALE | Viking Therapeutics, Inc. | 9,265 | 76.94 USD | |
| 28 Oct 2024 | SALE | Viking Therapeutics, Inc. | 23,082 | 77.68 USD | |
| 28 Oct 2024 | SALE | Viking Therapeutics, Inc. | 15,825 | 78.69 USD | |
| 28 Oct 2024 | EXERCISE | Viking Therapeutics, Inc. | 26,000 | 5.80 USD | |
| 28 Oct 2024 | SALE | Viking Therapeutics, Inc. | 7,967 | 80.65 USD | |
| 28 Oct 2024 | SALE | Viking Therapeutics, Inc. | 1,206 | 81.44 USD |